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Abstract:
Rhabdomyolysis is often due to a combination of environmental trigger(s) and genetic
predisposition; however, the underlying genetic cause remains elusive in many cases.
Mutations in CAV3 lead to various neuromuscular phenotypes with partial overlap, including
limb girdle muscular dystrophy type 1C (LGMD1C), rippling muscle disease, distal
myopathy and isolated hyperCKemia. Here we present a series of eight patients from seven
families presenting with exercise intolerance and rhabdomyolysis caused by mutations in
CAV3 diagnosed by next generation sequencing (NGS) (n=6). Symptoms included myalgia
(n=7), exercise intolerance (n=7) and episodes of rhabdomyolysis (n=2). Percussion-induced
rapid muscle contractions (PIRCs) were seen in five out of six patients examined. A
previously reported heterozygous mutation in CAV3 (p.T78M) and three novel variants
(p.V14I, p.F41S, p.F54V) were identified. Caveolin-3 immunolabeling in muscle was
normal in 3/4 patients however, immunoblotting showed more than 50% reduction of
caveolin-3 in five patients compared with controls. This case series demonstrates that
exercise intolerance, myalgia and rhabdomyolysis may be caused by CAV3 mutations and
broadens the phenotypic spectrum of caveolinopathies. In our series immunoblotting was a
more sensitive method to detect reduced caveolin-3 levels than immunohistochemistry in
skeletal muscle. Patients presenting with muscle pain, exercise intolerance and
rhabdomyolysis should be routinely tested for PIRCs as this may be an important clinical clue
for caveolinopathies, even in the absence of other “typical” features. The use of NGS may
expand current knowledge concerning inherited diseases, and unexpected/atypical
phenotypes may be attributed to well-known human disease genes.
Key Words: CAV3; Rhabdomyolysis; Myoglobinuria; Caveolinopathy; Exercise Intolerance;
Myalgia
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Highlights
 Here we present a series of eight patients with mutations in CAV3
 This case series broadens the phenotypic spectrum of caveolinopathies
 Exercise intolerance, myalgia and rhabdomyolysis may be caused by CAV3 mutations
 Rippling muscle contractions and PIRCs are clinical clues of caveolinopathies
 Immunoblotting may be more sensitive in detecting reduced caveolin-3 levels
Abbreviations:
ATPase: Adenosine triphosphatase
CAV3: Caveolin-3 (M-caveolin) – OMIM # 601253
CK: creatine kinase
COX: cytochrome oxidase
CPT2: Carnitine Palmitoyl Transferase 2
CRP: C-reactive protein
ECC: Excitation-contraction coupling
EM: Electron microscope
ESR: Erythrocyte sedimentation rate
H&E: Hematoxylin and eosin
LGMD1C: limb girdle muscular dystrophy type 1C
MHC: Myosin heavy chain
MRI: Magnetic resonance imaging
NADH-TR: Nicotinamide adenine dinucleotide-tetrazolium reductase
NGS: Next-generation sequencing
nNOS: Neuronal nitric oxidase synthase
PIRCs: percussion-induced rapid muscle contractions
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PFK: phosphofructokinase
RM: Acute Rhabdomyolysis
SDH: Succinic dehydrogenase
SR: Sarcoplasmic reticulum
WB: Western blotting
WES: Whole exome sequencing
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1 Introduction
Acute rhabdomyolysis (RM) is a serious event often requiring critical care management.
Precipitating causes include a range of environmental trigger(s) with and without a known
genetic predisposition [1]. In many cases no cause is found. Here we report eight patients
who on next-generation sequencing (NGS) were found to carry four heterozygous missense
CAV3 mutations after extensive earlier investigations had been negative. Our findings expand
the CAV3-related phenotypical spectrum, so far comprising limb girdle muscular dystrophy
type 1C (LGMD1C), rippling muscle disease, distal myopathy, isolated hyperCKemia and
familial hypertrophic cardiomyopathy [2].
2 Materials and methods:
Eight patients presenting with exercise intolerance, myalgia and/or recurrent RM who
remained genetically unresolved despite extensive previous investigations are reported. Six
patients (patients 1-5 and 8) were identified from a larger cohort of 225 patients with exercise
intolerance, myalgia and/or recurrent RM. DNA from patient 6 (the father of patient 5) was
assessed following a genetic diagnosis in his son. Patient 7 was genetically investigated
following muscle biopsy analysis. Approval was obtained from the regional ethics
committee, and informed consent was obtained from all subjects for genetic studies. Medical
notes were reviewed retrospectively and patients were reassessed following the genetic
diagnosis, except patients 1,3 and 4 who failed to attend follow up visits, and patient 6, who
is deceased. Clinical findings are summarized in Table 1, including: age of onset, age at
assessment, presenting symptom, recurrent RM and its triggers, reported rippling muscle
contraction, percussion-induced rapid muscle contractions (PIRCs) assessed during physical
exam (by a reflex hammer (percussion of a muscle)), muscle pain, muscle weakness assessed
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during physical exam, reported exercise intolerance (defined as pain and/or a cramp-like
sensation during exercise), fatigue and baseline serum creatine kinase (CK) levels.
Histopathological studies were performed as described in Supplementary Material.
Polyacrylamide gel electrophoresis and western blotting were performed as previously
described [3]. Blots were incubated with 43DAG/8D5 (β-dystroglycan, Leica Biosystems, 
NCL-b-DG, dil. 1/350) and caveolin-3 (BD Biosciences BD610421, dil. 1/350). Myosin
heavy chain staining with Coomassie blue on the post-blotted gel was used as a control for
protein loading and quality of the transfer. Bands were visualised with SuperSignal West
Pico Chemiluminescent Substrate detection (Life Technology) using AlphaInnotech
FluorChemR Q platform and AlphaViewR software v3.0. Densitometric analysis was
undertaken using ImageJ v1.47 software with data normalised to the density of the myosin
heavy chain band on the Coomassie blue stained post-blotted gel and expressed as a
percentage of the control sample.
DNA from six patients was sequenced by a NGS Illumina ‘Trusight One’ enrichment
panel; designed to screen for 60 relevant genes, previously associated or putatively linked
with RM (for review [1]). Mutations identified on NGS were confirmed by Sanger
sequencing. Patient 7 was evaluated by bi-directional sequence analysis for mutations in
CAV3 and patient 8 by whole exome sequencing (SOLiDTM). Whole exome sequencing was
performed as outlined previously [4]. Three μg of DNA was fragmented by sonication and 
ligated to SOLiDTM system sequencing adaptors. The resulting library was enriched for
exomic sequences using the SeqCap EZ Human Exome Library v2.0 exome capture system
(Nimblegen, Roche Diagnostics) and sequenced using a 5500XL Genetic Analyser (Life
Technologies). After sequencing and alignment, average coverage was 56-fold with 73% of
the exome covered to 20-fold or greater. Variant calling was performed using LifeScopeTM
2.5 (Life Technologies) and the resulting variants were filtered using ANNOVAR. The CAV3
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mutations were confirmation by bi-directional Sanger sequencing. Mutations were described
using the single letter nomenclature to describe non-synonymous variants.
3 Results:
The clinical history from each patient is outlined below and key findings are summarized
in Table 1. Patient 1 presented with fatigue, muscle pain, and recurrent episodes of
myoglobinuria (highest CK: 28,000 IU/L) without apparent trigger. Inflammatory markers
(CRP and ESR), HIV testing and auto-antibodies for auto-immune myositis were negative.
Plasma acylcarnitine profile, urine organic acids, fatty acid oxidation flux and CPT2 activity
in skin fibroblasts were all normal. Patient 2 presented with a longstanding history of muscle
pain and tenderness exacerbated by mild physical activities and exercise that interfered with
normal daily activities. Examination was unremarkable except for muscle pain evoked by
muscle palpation. Routine biochemistry was normal, apart from raised CK. Inflammatory
markers (CRP and ESR) and autoantibodies including ANA, GAD, Anti-DNA, Rheumatoid
Factor, Anti-Hu, Anti-Yo, Anti-Ri, were negative. Patient 3 had exercise intolerance
throughout adult life. RM occurred at age 37 following a few hours of moderate intensity
swimming. At the time he was also taking antibiotics for an infection. Severe pain and acute
muscle weakness were accompanied by myoglobinuria. A second episode was associated
with exercise (swimming) in conjunction with fever. A third episode occurred spontaneously
with no apparent precipitant. Patient 4 presented with exercise-related muscle cramps and
stiffness since childhood. Examination was unremarkable. He had hypoglycaemic seizures in
the neonatal period. Genetic testing for GLUT1, HADH and LPIN1 were normal. Patient 5
had muscle symptoms from childhood. He had mild muscle weakness, and could not perform
endurance activities. Paroxysmal weakness lasting 2-3 hours occurred after strenuous
exercise. Post exercise muscle pain was also a feature. Hypertrophic cardiomyopathy was
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diagnosed in his 40s during a routine health check. Extensive genetic investigations were
negative (including full mutation screening of VCP, DES, MYOT, CRYAB, ZASP, TTN,
targeted sequencing of POLG1 and PEO1, plus testing for large scale rearrangements and full
sequencing of muscle-extracted mtDNA). Muscle biopsy slides were not available for review.
Patient 6, the father of patient 5, presented with progressive muscle weakness from the fourth
decade and died aged 85. Muscle weakness initially involved the anterior thighs with
progression to the distal upper limbs later in life. He became wheelchair-dependent in his late
60s. He had no swallowing or respiratory difficulties and no facial or axial weakness, no
ptosis and a full range of eye movements. A muscle biopsy performed at 67 years was
reported as showing dystrophic features (muscle biopsy slides not available for review).
Genetic investigations for FKRP, VCP and dystrophin gene mutations and FSHD testing
were all negative. Patient 7 presented with exercise intolerance and muscle pain relieved by
rest. He occasionally experienced muscle cramps post exertion with muscle rippling. He had
mild proximal weakness (MRC 4+/5) with a modified Gowers’ manoeuvre. He walked with a
mild wide-based gait with everted flat feet and had mild tightness of the tendon achilles (-5
degrees bilaterally) and a mild lumbar lordosis. Muscle MRI showed mild fatty infiltration on
the rectus femoris, sartorius, biceps femoris, gastrocnaemius and semitendinosus muscles.
Serum lactate, acylcarnitine profile and routine biochemistry were normal. Patient 8 was an
elite athlete, but her high level training was complicated by severe exercise-induced myalgia.
On examination she had muscle hypertrophy especially marked in the lower limbs without
muscle weakness.
Four heterozygous CAV3 mutations were found: a previously described p.T78M
substitution (exon 2, c.233C>T) (Patients 3-6) located in the central hydrophobic trans-
membrane domain of the protein, and three novel substitutions: p.V14I (exon 1, c.40G>A)
(Patients 1 and 2) located in the N-terminal domain of the protein, p.F41S (exon 2,
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c.122C>T) (Patient 7) and p.F54V (exon 2, c.160T>G) (Patient 8), both within the
oligomerization domain.
Muscle biopsies (n=5) showed non-specific changes as seen in Fig 1 (Supplementary
Table 1). To investigate the effect of the mutations, caveolin-3 protein expression was
assessed by WB in five patients (Patients 1,2,4,7,8). Levels in four patients (Patients 1,2,4,8)
were reduced by more than 50% compared to controls (Fig 2). β-dystroglycan, used as a 
loading control, also had reduced levels in three of the samples (Patients 1,2,4). Caveolin-3
was markedly reduced on muscle tissue sections from Patient 7 and absent on WB on the
same tissue (Supplementary Fig 1).
4 Discussion
We present eight patients with myalgia (n=7), exercise intolerance (n=7) and recurrent
RM (n=2) who were found to carry mutations in CAV3; a few of them had been screened for
selected metabolic myopathies before NGS was performed. The use of NGS is rapidly
expanding the phenotypic spectrum of many neuromuscular disease genes, as sequencing of
disease genes is done in an unbiased approach, influencing future classification of disease
phenotypes and inherited disorders. This case series illustrates that a “metabolic phenotype”,
so far more frequently recognized in association with disorders of muscle metabolism (e.g.:
glycogen storage disorders and disorders of fatty acid metabolism), may also be part of the
phenotypic spectrum of proteins without immediately apparent primary metabolic link such
as caveolin-3. As opposed to disorders of muscle metabolism, there was no clear provoking
trigger for RM episodes in the reported cases. Patient 1 had no clear trigger for several
episodes of RM. It is unclear if exercise, infection or the combination of both contributed to
the RM episodes in patient 3, who also developed a third episode with no apparent trigger.
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CAV3 encodes caveolin-3, a muscle specific plasma membrane protein involved in
several processes related to the formation of caveolae, invaginations of the plasma
membrane. Autosomal dominant – and, less frequently, recessive – CAV3 mutations have
been implicated in hyperCKaemia, rippling muscle disease and LGMD1C [2]. Recurrent RM
has been previously described in only one patient with a CAV3 mutation, in whom NGS had
not been performed to exclude other genetic causes of RM [5]. Our findings suggest that
CAV3 mutations are a more frequent cause of myalgia, exertion intolerance and RM than
previously thought, and ought to be considered in patients presenting with such features. The
pathogenicity of the CAV3 variants identified and emerging genotype-phenotype correlations
are supported on several levels: 1) Exclusion of other genetic conditions predisposing to
similar symptoms by NGS; 2) the apparent association of CAV3-related symptoms with the
recurrent p.V14I and p.T78M substitutions; 3) and reduced caveolin-3 protein levels on WB.
Although myalgia, exercise intolerance and/or recurrent RM were the most prominent
features leading to referral for further assessment, other features – hyperCKaemia, reported
muscle rippling, PIRCs, muscle weakness and hypertrophic cardiomyopathy – were either
noted at presentation or evolved over time, emphasizing the previously observed wide and
overlapping phenotypical spectrum associated with CAV3 mutations. Along similar lines,
there was also marked intrafamilial variability, with one affected son (Patient 5) having a
different clinical picture to his father (Patient 6). PIRCs, a clinical hallmark of
caveolinopathies, were seen in five out of six patients examined, but were only assessed after
the genetic diagnosis had been established in 2 patients (patient 1 and 2). Four out of six
patients reported rippling muscle contraction. We believe PIRCs and rippling muscle
contraction are important clinical clues for caveolinopathies and should be assessed for in
patients presenting with exercise intolerance, myalgia and RM, even if other features
suggestive of a caveolinopathy are absent. Additional features in our series, which may or
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may not be related, included a history of neonatal hypoglycaemic seizures, previously
reported in one patient with CAV3 mutations [5], and paroxysmal muscle weakness, a novel
association.
Primary protein defects and absence of caveolin-3 staining on immunohistochemistry is
well documented in patients with caveolinopathies [2]. The key histopathological finding in
patient 7 was marked reduction of immunostaining for caveolin-3; in combination with an
absent band on WB, supporting the pathogenicity of the novel p.F41S substitution. Almost
complete absence of caveolin-3 on immunoblotting of patient 8 (p.F54V) supported
pathogenicity. These variants were absent from or expressed at a low frequency (0.0008%) in
ExAC, respectively. The three muscle biopsies from patients harbouring the p.V14I and
p.T78M substitutions showed only minor non-specific histochemical findings and normal
caveolin-3 immunostaining. However, reduced caveolin-3 levels on WB, supported the
pathogenicity of these mutations and suggested that WB may be the more sensitive method to
detect caveolin-3 deficiency. Reijneveld et al. also identified normal caveolin-3
immunostaining in two patients with hyperCKaemia, one with the p.T78M substitution [6].
Although these and our own observations indicate sufficient caveolin-3 expression to
generate a normal immunostaining pattern, it is currently uncertain if the p.V14I and p.T78M
substitutions exert their pathogenic effect through relative reduction or abnormal protein
function, or both.
Bioinformatics analysis (Table 2) predicts that p.T78M is damaging and it has been
described in association with long QT syndrome and sudden death [7, 8], isolated
hyperCKaemia [6], and rippling muscle disease with proximal myopathy in a patient carrying
a D4Z4 FSHD-sized allele [9]. Bioinformatic programs also predicted the p.F41S and p.F54V
substitutions to be pathogenic, while the p.V14I substitution was predicted to be benign by all
programs.
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The interaction between caveolin-3 and the skeletal muscle ryanodine receptor (RyR1),
involved in excitation-contraction coupling (ECC) and also implicated in virally- and
exercise induced myalgia and rhabdomyolysis [10, 11], could be of potential relevance to the
phenotype observed in our patients. Both caveolin-3 and RyR1 co-localize at the T-tubule
and sarcoplasmic reticulum (SR), and a critical role for caveolin-3 has been suggested in the
correct localization of RyR1 to the SR and as a modifier of ECC [12, 13].
The significance of β-dystroglycan reduction in three WB samples is uncertain, even 
though β-dystroglycan, is a known interactor of caveolins [14, 15]. Myosin heavy chain was 
also used as a protein loading control, ensuring that this observation is not due to uneven
loading of skeletal muscle protein.
A limitation of this study was the inability to perform co-segregation studies in other
family members to strengthen the pathogenicity of the CAV3 variants and to evaluate their
penetrance. In addition, future more detailed functional characterization may clarify the
precise pathogenic effect of the new CAV3 variants and their role in genetic counselling, and
additional genetic modifiers with potential synergistic effects may be identified.
5 Conclusions
In summary, myalgia, exertion intolerance and recurrent RM are features associated with
CAV3 mutations, highlighting the broad and expanding spectrum of caveolinopathies.
Rippling muscle contraction and PIRCs may be important clinical clues indicative of
caveolinopathies and should be assessed in patients who present with exertion related
symptoms. Non-specific changes in muscle biopsy do not exclude CAV3 mutations, and WB
and/or specific genetic testing should be performed if a caveolinopathy is strongly suspected
on clinical grounds.
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Legends:
Table 1: Key findings in patients with CAV3 mutations. Het: heterozygous; RM:
rhabdomyolysis; NA: not applicable; ND: no data; Rippling (reported): rippling muscle
contraction reported by the patient; PIRCs: percussion-induced rapid muscle contractions;
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LL: lower limbs; UL: upper limbs; CK: creatine kinase; ECG; electrocardiogram; NCS-
EMG: neurophysiology evaluation; CTS: carpal tunnel syndrome; MRI: magnetic resonance
imaging; Family history: Family history for neuromuscular symptoms.
Table 2: Frequency of the CAV3 mutations in ExAC and the in silico predictions for each
substitution.
Figure 1: Quadriceps muscle biopsies were available from four patients; patients 1 (I) & 2
(II) were biopsied as adults, while 4 (III) and 7 (IV) were biopsied at 14 years. The adults (Ia,
IIa; HE) and one child (IIIa; HE) showed minimal non-specific changes including occasional
small fibres. The second child (IVa; HE) showed mild myopathic changes with increased
fibre size variation, few small granular basophilic fibres, mild internal nucleation and focal
perimysial fatty infiltrate. Fibre typing was preserved in all cases with mild oxidative
abnormalities ranging from slight unevenness of stain to presence of a few mini-cores (Ib,
IIB, IIIB; NADH-TR). Occasional fibres expressed fetal myosin (IIId). Protein
immunoanalysis revealed normal sarcolemmal/basal lamina expression of the DAG complex
including caveolin-3 (Ic, IIc, IIIc) and beta-dystroglycan (Id, IId) except in patient 7 (IV),
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where a marked reduction was identifiable in sections (IVc). Caveolin-3 labeling in a non-
disease control (IVd). The bar in the bottom right represents 100 microns in length.
Figure 2: Western blots showed reduced levels of caveolin-3 and β-dystroglycan (β-DG) in 
patients with CAV3 mutations (A,B,C). P1: patient 1; P2: patient 2; P4: patient 4; P8: patient
8. Levels of caveolin-3 in patient 8 were calculated to be 0.12 of controls (using the longer
exposure blot). Myosin heavy chain (MHC) was used as a protein loading control.
Table 1:
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Table 2:
Substitu
tion
Nov
el
Freq
ExAC (%)
MutationT
aster Polyphen-2 SIFT
Provea
n
MutationAss
essor
(Fx impact)
cDNA
change Genomic coordinates
p.V14I yes 0.0519 Polymorphism Benign
Tolera
ted Neutral Neutral c.40G>A
3:8775602 G / A
(rs121909281)
p.F41S yes notpresent
Disease-
causing
Probably
damaging
Damag
ing
Deleteri
ous Medium c.122T>C 3:8787219 T / C
p.F54V yes 0.0008 Disease-causing Benign
Tolera
ted
Deleteri
ous Medium c.160T>G 3:8787257 T / G
p.T78M no 0.3038 Disease-causing
Probably
damaging
Tolera
ted Neutral Low c.233C>T
3:8787330 C / T
(rs72546668)
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Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8
DNA
analysis
CAV3
V14I V14I T78M T78M T78M T78M F41S F54V
Het Het Het Het Het Het Het Het
Ethnicity African Afro-
Caribbean
Caucasian Caucasian Caucasian Caucasian Caucasian Caucasian
Gender M F M M M M M F
Age of onset
/ age at
assessment
20s / 33 30s / 57 30s / 43 9 / 16 Childhood /
58
30s / 85 7 / 12 Late teens /
26
Presenting
symptom
Severe
fatigue,
myalgia
Calf pain Myalgia
following
physical
activity
Myalgia,
muscle
cramps
Myalgia,
Muscle
weakness,
difficulty to
keeping up
with peers
Muscle
weakness
Myalgia on
exertion,
fatigue,
difficulty to
keeping up
with peers
Severe
exercise-
induced
myalgia
Recurrent
RM
Yes No Yes No No ND No No
Trigger RM ND NA Exertion,
Antibiotics/in
fection,
Unknown
NA NA ND NA NA
Rippling
(reported)
/ PIRCs
Yes / Yes Yes / Yes ND / ND No / Yes Yes / Yes ND / ND Yes / No No / Yes
Myalgia Yes Yes Yes Yes Yes ND Yes Yes
Weakness Upper limbs Proximal
lower limbs
No No Handgrip –
mild
Proximal
(LL)
Distal (UL)
Handgrip
Proximal –
mild
No
Muscle
atrophy
ND Yes (Thigh) No No No Yes No No
Exercise
intolerance
Yes Yes Yes Yes Yes ND Yes Yes
Fatigue Yes Yes No No Yes ND Yes Yes
Basal CK 500 300 – 600 126 600 - 4000 142 280 300-685 217
ECG SR with
biphasic T
waves V4 to
V6
Normal ND Normal Abnormal ND Normal Normal
Echo
cardiogram
Normal ND ND Normal Abnormal ND Normal Normal
NCS-EMG Normal CTS ND Normal Normal Myopathic
changes
Normal Normal
Lower limb
muscle MRI
Normal Normal ND Normal ND ND Abnormal ND
Family
history
Negative Negative Negative Negative Affected
father (P6),
mother
(enlarged
heart), sister
(fatigue), son
(exercise
related
myalgia)
Affected son
(P5)
Father
(difficulty
with
mobility)
Negative
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